Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer

Subjects

Subjects :

Oncology
Cancer Research
medicine.medical_specialty
Radiation
Colorectal cancer
business.industry
0206 medical engineering
Locally advanced
02 engineering and technology
021001 nanoscience & nanotechnology
medicine.disease
020601 biomedical engineering
Capecitabine
Internal medicine
CRLX101
medicine
Radiology, Nuclear Medicine and imaging
0210 nano-technology
business
medicine.drug

Details

ISSN :

03603016

Volume :

99

Database :

OpenAIRE

Journal :

International Journal of Radiation Oncology*Biology*Physics

Accession number :

edsair.doi...........a64639285d26ed30a06875f8dd997e04

Full Text :

https://doi.org/10.1016/j.ijrobp.2017.06.162